Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David I Bernstein
Evidence for Cross-Protection but Not Type-Replacement Over the 11 Years After Human Papillomavirus Vaccine Introduction
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
Closing Editorial: Processes, Opportunities and Challenges After Introduction of Human Papillomavirus Vaccine
Sexual Health
Environmental
Public Health
Infectious Diseases
Occupational Health
Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine
Drugs
Pharmacology
S12.1 Human Papillomavirus Vaccines - Correlates of Protection Are Not Defined
Sexually Transmitted Infections
Dermatology
Infectious Diseases
Human Papillomavirus 9-Valent Vaccine for Cancer Prevention: A Systematic Review of the Available Evidence
Epidemiology and Infection
Epidemiology
Infectious Diseases
Laboratory Production in Vivo of Infectious Human Papillomavirus Type 11.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
A Novel Vaccine for Cervical Cancer: Quadrivalent Human Papillomavirus (Types 6, 11, 16 and 18) Recombinant Vaccine (Gardasil®)
Therapeutics and Clinical Risk Management
Protection Against Heterologous Human Papillomavirus Challenge by a Synthetic Lipopeptide Vaccine Containing a Broadly Cross-Neutralizing Epitope of L2
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Cervical Cancer and the Human Papillomavirus Vaccine
Journal of Family Planning and Reproductive Health Care
Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males
Drugs in R and D
Pharmacology
